Khaitan & Co advised Kotak Life Sciences Fund I and Alkemi Venture Fund II Scheme I in their primary investment in Zeroharm Sciences Pvt Ltd, a nutraceutical company.
Template Type
Deal Details
Banner Image
Image
Unique URL
/firm-matter/kotak-life-sciences-fund-i-and-alkemi-venture-fund-ii-scheme-i-investment-in-zeroharm-sciences
Back Link
/news-and-events
Date
Practice Area
Core Team
The core team consisted of Sanchit Agarwal (Partner), Pulkit Chaturvedi (Principal Associate), Aditi Gupta (Senior Associate), Jubin Jay (Senior Associate), Daryl Menezes (Associate), Shriya Garg (Associate), and Sameer Parihar (Associate).